7 Best Stocks for the Next 30 Days

Get them in a free Special Report, and get more Zacks Insights in our free e-newsletter, Profit from the Pros. Every issue includes a fresh Zacks #1 Bull Stock of the Day.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 05/21/2013

Company Name Symbol %Change
SCIENTIFIC L SCIL
8.00%
SUMMER INFAN SUMR
7.23%
FEDERAL MOGU FDML
6.13%
RADIANT LOGI RLGT
5.32%
NATUS MEDICA BABY
5.27%

Will Ciena Beat in 1Q?

by Mark Vickery

March 06, 2013 | Comments : 0 Recommended this article: (0)

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

Ciena Corp ( CIEN - Analyst Report ) is scheduled to release its first quarter 2013 results on March 7. Though the company posted a negative surprise of 14.3% in the last quarter, Ciena posted an average surprise of +4.9% over the last four quarters. Let’s see how things are shaping up for the company in this quarter.

Factors Affecting Growth this Past Quarter

Ciena reported dismal fourth-quarter results with the top line failing to meet the Zacks Consensus Estimate. Ciena’s loss per share widened on a year-over-year basis.

The company also reported margin contractions due to unfavorable product mix and higher-than-expected operating expenses.

Ciena expects a tepid first quarter due to reductions in order volume and deployment activity owing to the holiday season. For 2013, management remains optimistic and expects to gain market share, driven by continued spending from telecom carriers that remain focused on upgrading their networks. However, management hinted at subdued gross margins due to start-up costs related to new orders and its deployments.

Earnings Whispers?

The Zacks Consensus Estimate for the first quarter stands at a loss of 25 cents per share while that for fiscal 2013 stands at a loss of 29 cents per share.

There have been no revisions in the first quarter and 2013 estimates over the last 60 days. As a result, the Zacks Consensus Estimate for the two periods remain pinned at 25 cents and 29 cents, respectively.

The lack of downward movement in estimates signals that the first quarter might not be too different from the past quarters. This is also indicated by that fact that the stock carries a Zacks Rank #3 (Hold).

We caution against stocks with Zacks Ranks #4 and #5 (Sell rated stocks) going into the earnings announcement, especially when the company is seeing negative estimate revisions momentum.

Other Stocks to Consider

Our model states that a stock needs to have both a positive Zacks Earnings ESP and a Zacks Rank of #1, #2 or #3 to beat earnings estimates. You could, however, consider the following stocks that satisfy both criteria:

Energizer Holdings ( ENR - Analyst Report ) has a Zacks Rank #3 (Hold) and Zacks Earnings ESP of 0.78%.

Fiserv Inc. ( FISV - Analyst Report ) has a Zacks Rank #2 (Buy) and Zacks Earnings ESP of 0.76%.

Akamai Technologies ( AKAM - Analyst Report ) has a Zacks Rank #3 (Hold) and Zacks Earnings ESP of 2.7%.

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.